The annual Biotechnology Industry Position Survey shows the bullish sentiment for the Australian industry’s future continues, while the operating environment (economic and public policy) remains a concern. The survey was undertaken by AusBiotech and Grant Thornton Australia.
The industry’s confidence, reported in 2011, continues with 82% of respondents expecting their business to grow in the coming year, while 68% characterised last year as a good or excellent year. The expansionary approach to employment that emerged during 2009 persists with a majority of companies (58%) indicating they will increase staffing numbers in the coming year.
However, the Australian operating environment (economic and public policy) remains a concern for the growth of biotechnology companies, with two in five companies (38%) saying it was working against their growth.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze